Defeating AMR.
Enhancing antibiotic stewardship
Rapid and accurate ID, AST, MIC results enable healthcare providers to optimize treatment and avoid overprescribing or misprescribing antimicrobials. Our technology
CULTURE-FREE Microbiology®
Accurate testing. Within minutes. Rapidly detect, identify, and quantify pathogens in blood,
urine, and other body fluids Learn about our P-1000™ analyzer Clinical
Enhancing antibiotic stewardship
Rapid and accurate ID, AST, MIC results enable healthcare providers to optimize treatment and avoid overprescribing or misprescribing antimicrobials. Our technology
CULTURE-FREE Microbiology®
Accurate testing. Within minutes. Rapidly detect, identify, and quantify pathogens in blood,
urine, and other body fluids Learn about our P-1000™ analyzer Clinical
Total raised: $87.96M
Investors 3
| Date | Name | Website |
| - | Rafael Dev... | rdc.co.il/ |
| - | SCP Vitali... | scpvitalif... |
| - | Elron Elec... | elron.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 16.05.2022 | - | $22.96M | - |
| 01.07.2021 | - | $50M | Global Eme... |
| 17.02.2015 | - | $15M | - |
Mentions in press and media 4
| Date | Title | Description |
| 16.05.2022 | Pocared Diagnostics, an Israeli rapid infectious diseases diagnostics leader, secures a EUR 22 million EIB backing for completion of the development and commercialization of its rapid testing system | - First EIB support for medtech investment in Israel - Financing to accelerate development of rapid testing system to improve infectious disease diagnosis and antibiotics stewardship - Automated phenotypic testing, revolutionizing infectiou... |
| 01.07.2021 | POCARED Diagnostics Secures $50 Million Capital Commitment From GEM as Company envisages going public via SPAC merger | REHOVOT, Israel, July 1, 2021 /PRNewswire/ -- POCARED announced that it has signed an agreement with GEM Global Yield LLC SCS ("GEM"), the Luxembourg based private alternative investment group to provide POCARED with up to $50 Mil... |
| 01.07.2021 | POCARED Diagnostics Secures $50 Million Capital Commitment From GEM as Company envisages going public via SPAC merger | POCARED is on the verge of revolutionizing infectious disease diagnosis. The company will use the funds to complete development of its technology and commercial its system |
| 17.02.2015 | Pocared Diagnostics Closes $15M Funding | Pocared Diagnostics Ltd., a Rehovot, Israeli-based diagnostics and pre-analytical technology manufacturer, closed $15M in milestone-based funding. The company intends to use the funds to complete its clinical trials and increase manufacturi... |